Safety and drug quantification of the dapivirine vaginal ring and oral pre-exposure prophylaxis in breastfeeding mother–infant pairs (MTN-043): a phase 3B, open-label, randomised trial
Year: 2025
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet HIV
Authors: Lisa M Noguchi, Maxensia Owor, Nyaradzo M Mgodi, Brenda Gati Mirembe, Sufia Dadabhai, Elizea Horne, Holly Gundacker, Barbra A Richardson, Katherine Bunge, Rachel Scheckter, Mei Song, Mark A Marzinke, Peter L Anderson, Edward Livant, Cindy Jacobson, Jeanna M Piper, Nahida Chakhtoura, Sharon L Hillier, Jennifer E Balkus
Institutions: Johns Hopkins University, Jhpiego, Makerere University, University of Zimbabwe, Kamuzu University of Health Sciences, University of the Witwatersrand, Fred Hutch Cancer Center, University of Washington, Magee-Womens Research Institute, Family Health International 360, National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Public Health – Seattle & King County
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: Statistical and Data Management Center (SDMC): Microbicide Trials Network, Leadership and Operations Center (LOC): Microbicide Trials Network, G4296988315, Units for HIV/AIDS Clinical Trials Networks, G6061032065, International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group, Laboratory Center (LC): Microbicide Trials Network, G7784114671, UZ-UCSF CTU, Rustbelt Center for AIDS Research (Case/UHC-Pitt CFAR), The Johns Hopkins University-Blantyre Clinical Trials Unit, SDMC: HIV Prevention Trials Network, The Johns Hopkins University - Uganda Clinical Trials Unit, Wits HIV Research Group CLINICAL TRIAL UNIT (CTU) reapplication
OpenAlex ID: W4407397014